Cargando…

Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan

Clostridioides (Clostridium) difficile infection (CDI) is the leading cause of infectious diarrhoea in hospitalised patients, representing a substantial economic burden driven mainly by increased length of hospital stay (LoS). Currently in Japan, limited evidence on CDI-associated excess LoS is avai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, T., Stanhope, S., Sugitani, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118723/ https://www.ncbi.nlm.nih.gov/pubmed/32115019 http://dx.doi.org/10.1017/S0950268820000606

Ejemplares similares

1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014)

Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile
por: Sewell, Bernadette, et al.
Publicado: (2014)

1921. Attributable Inpatient Costs of Hospital-Onset Clostridium difficile Infection: A Nationwide Case–Control Study in Japan
por: Fukuda, Haruhisa, et al.
Publicado: (2018)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

The Impact of Appendectomy in Clostridium difficile Infection and Length of Hospital Stay
por: Essrani, Rajesh, et al.
Publicado: (2020)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
por: Hiraki, Masayuki, et al.
Publicado: (2021)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018)

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
por: Zhang, Dongmu, et al.
Publicado: (2018)

Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections
por: Mitchell, Brett G, et al.
Publicado: (2012)

2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
por: Tijerina, Laura, et al.
Publicado: (2019)

Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?
por: Patel, Devangi, et al.
Publicado: (2023)

Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes
por: Madden, Gregory R., et al.
Publicado: (2022)

The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review
por: Riley, Thomas V., et al.
Publicado: (2018)

Detection, Characterization and Antibiotic Susceptibility of Clostridioides (Clostridium) difficile in Meat Products
por: Muratoglu, Karlo, et al.
Publicado: (2020)

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
por: Lawrence, Jody, et al.
Publicado: (2020)

Clostridioides (Clostridium) difficile in neonatal foals and mares at a referral hospital
por: Weese, Jeffrey Scott, et al.
Publicado: (2021)

COVID-19 and coinfection with Clostridioides ( Clostridium ) difficile in an infant with gastrointestinal manifestation
por: Oba, Jane, et al.
Publicado: (2020)

Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
por: Lang, Vanessa, et al.
Publicado: (2022)

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
por: Venhorst, Jennifer, et al.
Publicado: (2022)

16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2021)

Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022)

Costs Associated with the Treatment of Clostridioides Difficile Infections
por: Sierocka, Aleksandra, et al.
Publicado: (2021)

Determining Mortality Rates Attributable to Clostridium difficile Infection
por: Hota, Susy S., et al.
Publicado: (2012)

Attributing Cause of Death for Patients with Clostridium difficile Infection
por: Gilca, Rodica, et al.
Publicado: (2012)

Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2022)

2372. PCR Ribotype and Antimicrobial Susceptibility of Clostridioides (Formerly Clostridium) difficile in Korea
por: Hoo Jeon, Cheon, et al.
Publicado: (2019)

Genotyping and Antimicrobial Susceptibility of Clostridium perfringens and Clostridioides difficile in Camel Minced Meat
por: Fayez, Mahmoud, et al.
Publicado: (2021)

Spore-Forming Clostridium (Clostridioides) difficile in Wastewater Treatment Plants in Western Australia
por: Chisholm, Jessica M., et al.
Publicado: (2022)

Risk Factors Associated with Recurrent Clostridioides difficile Infection
por: Negrut, Nicoleta, et al.
Publicado: (2020)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

2351. Rate and Consequences of Missed Clostridioides (Clostridium) difficile Infection Diagnosis from Non-disclosure of Clostridioides difficile Multiplex PCR Results. Two-Hospital Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2016)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Developing Gut Microbiota Exerts Colonisation Resistance to Clostridium (syn. Clostridioides) difficile in Piglets
por: Grześkowiak, Łukasz, et al.
Publicado: (2019)

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
por: Sartelli, Massimo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m08na1k3a9n942qhgd8c6qtjc7